Thursday, January 19, 2023 9:49:53 AM
Bid x Size
$271.06 x 1 Ask x Size $272.91 x 3
Volume 48,899
https://stockcharts.com/h-sc/ui?s=BGNE
BeiGene Says Brukinsa Gets UK Marketing Authorization for Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma
MT NEWSWIRES
08:38 AM EST, 01/19/2023 (MT Newswires) -- BeiGene (BGNE) said Thursday that the UK Medicines and Healthcare products Regulatory Agency has granted marketing authorizations for Brukinsa for the treatment of both chronic lymphocytic leukemia and marginal zone lymphoma.
(con't)
Recent BGNE News
- BeiGene Provides Update on FDA Advisory Committee Vote on Benefit-Risk Profile of PD-1 Inhibitors, including TEVIMBRA®, for Treatment of ESCC and Gastric/GEJ Cancers • Business Wire • 09/26/2024 10:21:00 PM
- がん領域の世界的イノベーション企業であるベイジーン、シャリニ・シャープを役員に任命 • Business Wire • 09/26/2024 06:26:00 PM
- Globaler Onkologie-Innovator BeiGene ernennt Shalini Sharp in sein Board of Directors • Business Wire • 09/26/2024 03:37:00 PM
- BeiGene, innovateur mondial en oncologie, nomme Shalini Sharp au conseil d'administration • Business Wire • 09/26/2024 01:46:00 PM
- Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors • Business Wire • 09/26/2024 10:00:00 AM
- Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope • AllPennyStocks.com • 09/17/2024 09:01:00 PM
- BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior Chemotherapy • Business Wire • 09/17/2024 11:00:00 AM
- Tislelizumab, inibidor PD-1 da BeiGene, é aprovado no Brasil para o tratamento de carcinoma espinocelular de esôfago (ESCC) e câncer de pulmão de células não pequenas (NSCLC) • Business Wire • 09/16/2024 12:00:00 PM
- BeiGene präsentiert TEVIMBRA®-Daten bei Lungen- und Magen-Darm-Krebs auf dem ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene présente les données de TEVIMBRA® sur les cancers pulmonaires et gastro-intestinaux au Congrès de l’ESMO 2024 • Business Wire • 09/10/2024 06:59:00 PM
- BeiGene annonce la mise à jour de la formation de son équipe de direction commerciale • Business Wire • 09/09/2024 06:52:00 PM
- BeiGene gibt Wechsel im kommerziellen Führungsteam bekannt • Business Wire • 09/09/2024 06:51:00 PM
- BeiGene Announces Updates to Commercial Leadership Team • Business Wire • 09/09/2024 11:00:00 AM
- BeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024 • Business Wire • 09/09/2024 05:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 11:29:23 AM
- BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/28/2024 10:01:00 AM
- BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL • Business Wire • 08/26/2024 10:00:00 AM
- ベイジーン、2024年第2四半期決算および事業に関する最新情報を発表し、グローバル成長の次なる段階へ • Business Wire • 08/08/2024 08:46:00 PM
- BeiGene公布2024年第二季財務業績和公司最新情況,進入全球成長的新階段 • Business Wire • 08/08/2024 12:23:00 PM
- BeiGene startet mit der Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 und Unternehmens-Updates in die nächste Phase seines globalen Wachstums • Business Wire • 08/08/2024 12:22:00 PM
- BeiGene entame la prochaine phase de sa croissance mondiale en annonçant ses résultats financiers du deuxième trimestre 2024 et des nouvelles de l’entreprise • Business Wire • 08/08/2024 12:22:00 PM
- Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 08/07/2024 11:32:45 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 10:04:19 AM
- BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates • Business Wire • 08/07/2024 10:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM